Insights

Innovative AI Platform Semalytix's Pharos platform leverages cutting-edge AI and large language models to analyze vast amounts of real-world data, providing pharmaceutical companies with actionable patient insights. This positions the company as a valuable partner for pharma firms seeking to enhance patient-centric strategies through advanced analytics.

Growing Financial Backing Recent successful funding rounds totaling over 12 million USD signal strong investor confidence and financial stability, enabling Semalytix to expand its service offerings and target larger pharmaceutical clients increasingly looking for AI-driven solutions.

Market Expansion Potential With more than 40 projects completed for the pharmaceutical industry and a revenue range of 1 to 10 million USD, Semalytix demonstrates proven market traction and growth potential, making it attractive for enterprise pharma companies aiming for competitive advantages.

Specialized Industry Focus Semalytix’s focus on serving pharmaceutical companies with tailored AI solutions creates opportunities to develop strategic partnerships and upsell services within the healthcare sector, especially as pharma firms seek more patient insights for product development and marketing.

Competitive Positioning Compared to larger competitors, Semalytix’s niche specialization in real-world data analysis and patient-centric insights provides a distinctive value proposition that can be emphasized to persuade pharma companies to adopt their innovative AI platform.

Semalytix GmbH Tech Stack

Semalytix GmbH uses 8 technology products and services including WordPress, NoSQL, Atlassian Jira, and more. Explore Semalytix GmbH's tech stack below.

  • WordPress
    Content Management System
  • NoSQL
    Database
  • Atlassian Jira
    Issue Trackers
  • React
    Javascript Frameworks
  • Java
    Programming Languages
  • Cloudflare Bot Management
    Security
  • ZURB Foundation
    UI Frameworks
  • Akismet
    Web Platform Extensions

Semalytix GmbH's Email Address Formats

Semalytix GmbH uses at least 2 format(s):
Semalytix GmbH Email FormatsExamplePercentage
First.Last@semalytix.deJohn.Doe@semalytix.de
96%
Last@semalytix.deDoe@semalytix.de
4%
First.Last@semalytix.comJohn.Doe@semalytix.com
89%
Last@semalytix.comDoe@semalytix.com
5%
First.Last@semalytix.comJohn.Doe@semalytix.com
6%

Frequently Asked Questions

What is Semalytix GmbH's official website and social media links?

Minus sign iconPlus sign icon
Semalytix GmbH's official website is semalytix.com and has social profiles on LinkedIn.

What is Semalytix GmbH's NAICS code?

Minus sign iconPlus sign icon
Semalytix GmbH's NAICS code is 5112 - Software Publishers.

How many employees does Semalytix GmbH have currently?

Minus sign iconPlus sign icon
As of December 2025, Semalytix GmbH has approximately 51 employees across 2 continents, including EuropeAsia. Key team members include Chief Product Officer, Managing Director, Co-Founder: J. J.Vp Global Marketing: S. R.Vice President Of Business Development: K. W.. Explore Semalytix GmbH's employee directory with LeadIQ.

What industry does Semalytix GmbH belong to?

Minus sign iconPlus sign icon
Semalytix GmbH operates in the Software Development industry.

What technology does Semalytix GmbH use?

Minus sign iconPlus sign icon
Semalytix GmbH's tech stack includes WordPressNoSQLAtlassian JiraReactJavaCloudflare Bot ManagementZURB FoundationAkismet.

What is Semalytix GmbH's email format?

Minus sign iconPlus sign icon
Semalytix GmbH's email format typically follows the pattern of First.Last@semalytix.de. Find more Semalytix GmbH email formats with LeadIQ.

When was Semalytix GmbH founded?

Minus sign iconPlus sign icon
Semalytix GmbH was founded in 2015.

Semalytix GmbH

Software DevelopmentNorth Rhine-westphalia, Germany51-200 Employees

Welcome to Semalytix!

Semalytix, the trailblazer in AI-driven innovations, empowers pharmaceutical companies to embrace a patient-centric approach like never before. With their revolutionary Pharos platform, fuelled by state-of-the-art AI and LLM technology, Semalytix undertakes the colossal task of consuming and analysing millions of forum posts, social media discussions, and CRM system records in the blink of an eye.

Pharos becomes the conduit for capturing and harnessing the pulse of real-world perceptions and experiences shared by both healthcare practitioners and patients in the here and now. Through its captivating living reports, Pharos bestows invaluable insights upon pharmaceutical giants, guiding them to laser-focus on their customers' genuine needs. It unlocks the profound understanding of what truly holds the potential to enhance their well-being, transforming lives in ways previously unimagined. 

Founded in 2015, Semalytix has grown to a team size of 75 employees and has executed more than 40 projects with the pharmaceutical industry with a total volume of EUR 3.8M between 2015 – 2019.

Section iconCompany Overview

NAICS Code
5112 - Software Publishers
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    Semalytix GmbH's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Semalytix GmbH's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.